Key result
One week of human growth hormone raises triglycerides ~30% in nondiabetics, driven by VLDL-2 increases.
Why the study?
The impact of moderately elevated human growth hormone concentrations, as seen in insulin dependent diabetic patients, on plasma lipoproteins was unclear.
Does human growth hormone administration increase plasma lipoprotein concentrations in nondiabetic persons?
Does human growth hormone administration increase plasma lipoprotein concentrations in nondiabetic persons?
Answers are grounded in this paper and cite their sources.
Short-term administration of human growth hormone in nondiabetic individuals significantly increases total plasma triglycerides and atherogenic VLDL-2 remnants.
To evaluate whether the moderately elevated human growth hormone concentration, seen in insulin dependent diabetic patients, has any impact on lipoproteins, human growth hormone was given to nondiabetic persons in doses which would bring their plasma human growth hormone concentration up in the same level as seen in insulin dependent diabetic patients. After one week of treatment with human growth hormone we found total plasma triglyceride to be significantly raised (0.98 mmol/l +/- 0.28 mmol/l (mean +/- SD) before versus 1.27 mmol/l +/- 0.38 mmol/l (mean +/- SD) after treatment). Very low density lipoprotein (VLDL) was separated into two fractions (VLDL-1 and VLDL-2) of which VLDL-2 is regarded as a VLDL-remnant which is suggested to be of importance for development of atherosclerosis. After one week of human growth hormone treatment there were no changes in VLDL-1 concentrations whereas a significant raise in VLDL-2 triglyceride and VLDL-2 cholesterol was seen.
No takes yet. Share an insight, caveat, or question.
Møller et al. (1989) studied Nondiabetic persons. Human growth hormone vs. Baseline (before treatment) was evaluated on Total plasma triglyceride. One week of human growth hormone treatment in nondiabetic persons significantly raised total plasma triglyceride from 0.98 mmol/l to 1.27 mmol/l, driven by increases in VLDL-2 fractions.
Synapse has enriched 10 related papers. Consider them for comparative context: